Stocks / NASDAQ / Galena Biopharma, Inc.

Galena Biopharma, Inc.

Our Opinion

Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs. Because of the testing required for these therapeutics, they are on the exploit list.

Company Description

Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs. It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. [Source: MarketWatch]

Company Website: https://galenabiopharma.com